Travere Therapeutics Interest Expense 2011-2025 | TVTX

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Travere Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.3 M	11 M	19.7 M	19.1 M	18.8 M	9.81 M	4.42 M	4.73 M	7.7 M	7.4 M	-	84.1 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19.7 M	84.1 K	10.4 M

Quarterly Interest Expense Travere Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-526 K	549 K	-	520 K	-3.5 M	238 K	-	335 K	-201 K	2.9 M	-	2.8 M	3 M	2.5 M	-	654 K	216 K	-1.09 M	-	553 K	426 K	-190 K	-	-496 K	125 K	-302 K	-	-90 K	-403 K	121 K	-	557 K	382 K	126 K	-	151 K	-206 K	210 K	2.21 M	-314 K	522 K	311 K	-10.3 M	2.6 M	-2.18 M	-	-874 K	-	-5	-41.6 K	500	26.8 K	-26.5 K	-17.3 K	500	1.5 K	1 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3 M	-10.3 M	27.2 K